Mary Sheon, Small Heather Yvonne, Siwy Justyna, Mullen William, Giri Ashok, Delles Christian
From the BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland (S.M., H.Y.S., W.M., C.D.); Department of Biochemical Sciences, CSIR-National Chemical Laboratory, Pune, India (S.M., A.G.); and Mosaiques Diagnostics GmbH, Hannover, Germany (J.S.).
Hypertension. 2017 May;69(5):910-918. doi: 10.1161/HYPERTENSIONAHA.116.08826. Epub 2017 Mar 27.
The kidney is centrally involved in blood pressure regulation and undergoes extensive changes during pregnancy. Hypertension during pregnancy may result in an altered urinary peptidome that could be used to indicate new targets of therapeutic or diagnostic interest. The stroke-prone spontaneously hypertensive rat (SHRSP) is a model of maternal chronic hypertension. Capillary electrophoresis-mass spectrometry was conducted to interrogate the urinary peptidome in SHRSP and the control Wistar-Kyoto strain at three time points: prepregnancy and gestational days 12 and 18. The comparison within and between the Wistar-Kyoto and SHRSP peptidome at all time points detected 123 differentially expressed peptides (fold change >1.5; <0.05). Sequencing of these peptides identified fragments of collagen α-chains, albumin, prothrombin, actin, serpin A3K, proepidermal growth factor, and uromodulin. Uromodulin peptides showed a pregnancy-specific alteration in SHRSP with a 7.8-fold (<0.01) and 8.8-fold (<0.05) increase at gestational days 12 and 18, respectively, relative to the Wistar-Kyoto. Further investigation revealed that these peptides belonged to the polymerization-inhibitory region of uromodulin. Two forms of uromodulin (polymerization competent and polymerization incompetent) were found in urine from both Wistar-Kyoto and SHRSP, where the polymerization-incompetent form was increased in a pregnancy-specific manner in SHRSP. Nifedipine-treated pregnant SHRSP showed only polymerization-competent uromodulin, indicating that calcium may be mechanistically involved in uromodulin polymerization. This study highlights, for the first time, a potential role of uromodulin and its polymerization in hypertensive pregnancy.
肾脏在血压调节中起核心作用,且在孕期会发生广泛变化。孕期高血压可能导致尿肽组改变,这可用于指示具有治疗或诊断意义的新靶点。易卒中型自发性高血压大鼠(SHRSP)是母体慢性高血压的模型。采用毛细管电泳-质谱法在三个时间点检测SHRSP和对照Wistar-Kyoto品系的尿肽组:孕前以及妊娠第12天和第18天。在所有时间点对Wistar-Kyoto和SHRSP肽组进行组内和组间比较,检测到123种差异表达肽(倍数变化>1.5;<0.05)。对这些肽进行测序,鉴定出胶原蛋白α链、白蛋白、凝血酶原、肌动蛋白、丝氨酸蛋白酶抑制剂A3K、前表皮生长因子和尿调节蛋白的片段。相对于Wistar-Kyoto,尿调节蛋白肽在SHRSP中呈现妊娠特异性改变,在妊娠第12天和第18天分别增加7.8倍(<0.01)和8.8倍(<0.05)。进一步研究表明,这些肽属于尿调节蛋白的聚合抑制区域。在Wistar-Kyoto和SHRSP的尿液中均发现了两种形式的尿调节蛋白(具有聚合能力和不具有聚合能力),其中不具有聚合能力的形式在SHRSP中以妊娠特异性方式增加。硝苯地平治疗的妊娠SHRSP仅显示具有聚合能力的尿调节蛋白,表明钙可能在机制上参与尿调节蛋白的聚合。本研究首次强调了尿调节蛋白及其聚合在高血压妊娠中的潜在作用。